Answers - Finance

Many people profess to be patient investors. In reality, not many can stand the heat of waiting their investments to turn around. You can identify such investors by asking the

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

m the reason why they invest on their stocks. If they said that they invest because such and such has an exciting products in the pipeline, then they are most likely are not g

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ing to be patient with that investment.

If they admit that things look gloomy for their investment but, they believe that the company will turn that around with certain new e

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

xecutions, then they are patient investors. The truth is turnaround investors are patient investors. They are willing to invest in a seemingly gloomy company with the expectat

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

on that things will change. No, it is not a stream of baseless hope. It is the patience to wait until the company can sort its mess out. That is hard to do, even for the most-

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

easoned turnaround investors. The reason is simple. You invest in companies that people love to hate. You need to have strong conviction in order to stay on the course. A lot

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

of novice investors would buy some beaten down companies, only to sell it later due to emotional reasons.

For instance, one folk might talked unfavorably about your company a

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

d you start to think that maybe he was right. After a while, another folk would talk some other terrifying things about your company and your mind started to tremble. At that

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

oint, you could not wait to dump your investments in this stock and you were glad you sold the stock. That happens a lot and that is the reason why turnaround investors are re

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

warded so much. Since not a lot of investors are willing to wait that long, the stock price can be bought at a much lower price than normal. This increases your potential retu

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

n.

What are examples of turnaround investments? Hindsight is 20-20. But, let me give a few examples in the past. Altria Inc. was a good turnaround investment in the early 200

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

s. It was hit by lawsuits left and right and nobody is willing to buy a stock with 'tobacco' labelled in them. Fast forward five years later, people still do not have a favora

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ble view on tobacco but Altria stock price increase anyway. It is not a mere penny increase that we are talking about. Altria increases more than 200% since its low price in t

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

e year 2000. How about Seagate Technology in the middle of last year? Analysts worry about the competition from flash disk which would cripple the hard-drive industry forever.

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

The result? Seagate stock price rose almost 100% within one year. Not a bad return for investing in un-loved companies.

One final example would be the pharmaceutical companie

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

s. Concerns about their future pipeline depressed their stock price for much of 2005. In 2006, when it is clear that the pipeline is not all dry, stock price rose steadily to

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

eflect that change. You could have bought Merck shares in the $ 26 range last year and your investment would have gained 36% thus far. This is despite the uncertainty revolvin

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

around it. When the vioxx case is all settled, I think the stock price can rise approaching the pre-vioxx announcement.

The key here though is to be knowledgeable about your

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

companies and be patient. This way, you will have a strong conviction about your investment and you will not sell a potentially good investment portfolio. That is not easy to

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

do but you will get better at it with practice. For starter, our website features a regular commentary that gives you free investing idea about potential turnaround investment

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/103933/answers-Turnaround-Investors-and-Patience.html">Turnaround Investors and Patience</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/103933/answers-Turnaround-Investors-and-Patience.html]Turnaround Investors and Patience[/url]

Is it possible to go from bottom line worker to CEO in a Corporation in America? In fact history shows it is. We have had CEOs of McDonalds rise from lobby trash patrol. The CEO and CFO of Enterprise Rent-a-Car went from car washers to their positions. Often even with such examples critics will say that it is not possible today?

Cross auction arbitrage is where you buy something at one auction to resell at another auction. It’s very common practice at offline salerooms where I know many people who buy at a local town auction where visitors are few and products often go below market value. Those items are carted off to bigger auction salerooms in major towns and cities, including larger London auction houses like Sotheby’s and Phillips. City and big town auctions often attract hundreds of international bidders with deep pockets and keen to bid high, unlike their small town counterparts which are often poorly advertised.

There are some basic errors that you should avoid while writing a press release. The sentences which you use must not be too long. This gives a completely professional look to your write up and makes it very readable. Avoid writing cliches, this is a thing of the past and now you can no longer attract attention from anyone for this.

Tags

Links

Answers - Turnaround Investors and Patience

Related Articles: